FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157099713> ?p ?o ?g. }

• W3157099713 startingPage "11" @default.
• W3157099713 abstract "In the rarified realm of biotechnology patent law, 2019 was one of stasis, change, reaction, and challenges to practitioners, patentees, those discontented with patents, and the judiciary itself. The year saw a comeback of sorts for the doctrine of equivalents, which has been a quiet area of the law since the Supreme Court’s last word in Festo v. Shoketsu Kinzoku Kogyo Kabushiki Co. in 2002. In 2019 there were no fewer than seven cases decided by the Federal Circuit involving the doctrine, and its primary antithesis, the doctrine of prosecution history estoppel. The perennial issue of subject matter eligibility remained uncertain, with the Federal Circuit deciding that method of treatment claims were patent-eligible as being an application of a natural law (and the Supreme Court taking the Solicitor General’s advice and not granting certiorari to review the wisdom of this dichotomy). Diagnostic method claims were another matter, with the Federal Circuit maintaining its jurisprudence that claims to such methods are almost per se patent-ineligible. In doing so, however, its Athena Diagnostics, Inc. v. Mayo Collaborative Services LLC decision illustrated a court in frank internal disagreement (if not disarray) in denying patentee’s petition for rehearing en banc. The Supreme Court weighed in on the extent to which the Leahy-Smith America Invents Act changed the scope of novelty-destroying prior art (saying it didn’t, despite an amicus brief to the contrary by the Act’s co-author, Rep. Lamar Smith), and Section 112(a) came under scrutiny on both written description and enablement issues. Finally, as a fixed constant in an otherwise changing universe, the interference over CRISPR technology between the Broad Institute and its colleagues and the University of California, Berkeley and its collaborators maintained its measured pace to a determination of who was first to invent CRISPR, and, accordingly, who owns this important technology. Admittedly, choosing the top ten judicial decisions suffers from an inevitable degree of subjectivity. However, we believe these decisions are among the most important decisions of the year in biotechnology patent law even if others might prefer to substitute a case or two for those on our list. All of the decisions discussed in this article were delivered during the 2019 calendar year." @default.
• W3157099713 created "2021-05-10" @default.
• W3157099713 creator A5069393285 @default.
• W3157099713 creator A5077012602 @default.
• W3157099713 date "2021-01-01" @default.
• W3157099713 modified "2023-09-25" @default.
• W3157099713 title "Biotechnology Patent Law Top Ten of 2019: Secret Sales, Denied Appeals, and the Promise of Coronavirus Cures" @default.
• W3157099713 hasPublicationYear "2021" @default.
• W3157099713 type Work @default.
• W3157099713 sameAs 3157099713 @default.
• W3157099713 citedByCount "0" @default.
• W3157099713 crossrefType "journal-article" @default.
• W3157099713 hasAuthorship W3157099713A5069393285 @default.
• W3157099713 hasAuthorship W3157099713A5077012602 @default.
• W3157099713 hasConcept C144024400 @default.
• W3157099713 hasConcept C17744445 @default.
• W3157099713 hasConcept C199539241 @default.
• W3157099713 hasConcept C2776050585 @default.
• W3157099713 hasConcept C2776211767 @default.
• W3157099713 hasConcept C2778272461 @default.
• W3157099713 hasConcept C2780697943 @default.
• W3157099713 hasConcept C2984145337 @default.
• W3157099713 hasConcept C34974158 @default.
• W3157099713 hasConcept C46415393 @default.
• W3157099713 hasConcept C71043370 @default.
• W3157099713 hasConcept C87501996 @default.
• W3157099713 hasConceptScore W3157099713C144024400 @default.
• W3157099713 hasConceptScore W3157099713C17744445 @default.
• W3157099713 hasConceptScore W3157099713C199539241 @default.
• W3157099713 hasConceptScore W3157099713C2776050585 @default.
• W3157099713 hasConceptScore W3157099713C2776211767 @default.
• W3157099713 hasConceptScore W3157099713C2778272461 @default.
• W3157099713 hasConceptScore W3157099713C2780697943 @default.
• W3157099713 hasConceptScore W3157099713C2984145337 @default.
• W3157099713 hasConceptScore W3157099713C34974158 @default.
• W3157099713 hasConceptScore W3157099713C46415393 @default.
• W3157099713 hasConceptScore W3157099713C71043370 @default.
• W3157099713 hasConceptScore W3157099713C87501996 @default.
• W3157099713 hasIssue "2" @default.
• W3157099713 hasLocation W31570997131 @default.
• W3157099713 hasOpenAccess W3157099713 @default.
• W3157099713 hasPrimaryLocation W31570997131 @default.
• W3157099713 hasRelatedWork W1479872230 @default.
• W3157099713 hasRelatedWork W1501362172 @default.
• W3157099713 hasRelatedWork W1561178204 @default.
• W3157099713 hasRelatedWork W1572218825 @default.
• W3157099713 hasRelatedWork W16527977 @default.
• W3157099713 hasRelatedWork W2003135302 @default.
• W3157099713 hasRelatedWork W2411221024 @default.
• W3157099713 hasRelatedWork W247295976 @default.
• W3157099713 hasRelatedWork W2509155936 @default.
• W3157099713 hasRelatedWork W2560533775 @default.
• W3157099713 hasRelatedWork W2594206242 @default.
• W3157099713 hasRelatedWork W2730603846 @default.
• W3157099713 hasRelatedWork W2746780930 @default.
• W3157099713 hasRelatedWork W304689019 @default.
• W3157099713 hasRelatedWork W3121617622 @default.
• W3157099713 hasRelatedWork W318443433 @default.
• W3157099713 hasRelatedWork W415639308 @default.
• W3157099713 hasRelatedWork W961881670 @default.
• W3157099713 hasRelatedWork W2136890069 @default.
• W3157099713 hasRelatedWork W309404650 @default.
• W3157099713 hasVolume "19" @default.
• W3157099713 isParatext "false" @default.
• W3157099713 isRetracted "false" @default.
• W3157099713 magId "3157099713" @default.
• W3157099713 workType "article" @default.